Lutea A A de Jong

Receptor-ligand binding assays: technologies and applications.

Rainer Bischoff, R. Bischoff, D. Uges, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Purification and characterization of the recombinant human dopamine D2S receptor from Pichia pastoris.

R. Bischoff, S. Grünewald, D. Uges, 2004, Protein expression and purification.

Assessment of medication use during pregnancy by Web-based questionnaires, pharmacy records and serum screening.

A. Verbeek, E. V. van Puijenbroek, N. Roeleveld, 2019, Reproductive toxicology.

Development of a multiplex non-radioactive receptor assay: the benzodiazepine receptor, the serotonin transporter and the beta-adrenergic receptor.

C. Jeronimus-Stratingh, Lutea A A de Jong, T. Cremers, 2007, Rapid communications in mass spectrometry : RCM.

Development and validation of a radioreceptor assay for the determination of morphine and its active metabolites in serum.

K. Krämer, R. Bischoff, D. Uges, 2005, Journal of pharmaceutical and biomedical analysis.

Determination of the benzodiazepine plasma concentrations in suicidal patients using a radioreceptor assay.

F. Zitman, K. Ensing, Lutea A A de Jong, 2004, Journal of analytical toxicology.

Prolonged Ketamine and Norketamine Excretion Profiles in Urine After Chronic Use

C. D. De Jong, Lutea A A de Jong, M. Böttcher, 2020, Journal of clinical psychopharmacology.

The risk of emerging new psychoactive substances: The first fatal 3-MeO-PCP intoxication in The Netherlands.

Lutea A A de Jong, W. Duijst, E. J. Olyslager, 2019, Journal of forensic and legal medicine.

Bioelectrical Impedance Measurements for Assessment of Kidney Function in Critically Ill Patients.

P. Spronk, Lutea A A de Jong, H. V. van Kan, 2019, Critical care medicine.